Anti-CYP7B1 antibody [EPR8395] - BSA and Azide free
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal CYP7B1 antibody. Carrier free. Suitable for WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
Cytochrome P450 7B1, 24-hydroxycholesterol 7-alpha-hydroxylase, 25/26-hydroxycholesterol 7-alpha-hydroxylase, 3-hydroxysteroid 7-alpha hydroxylase, Oxysterol 7-alpha-hydroxylase, CYP7B1
- WB
Unknown
Western blot - Anti-CYP7B1 antibody [EPR8395] - BSA and Azide free (AB248849)
This data was developed using ab138497, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-CYP7B1 antibody [EPR8395] (<a href='/en-us/products/primary-antibodies/cyp7b1-antibody-epr8395-ab138497'>ab138497</a>) at 1/1000 dilution
Lane 1:
PC3 lysate at 30 µg
Lane 2:
Human fetal liver lysate at 30 µg
Lane 3:
Human fetal kidney lysate at 30 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 58 kDa
Observed band size: 55 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-CYP7B1 antibody [EPR8395] - BSA and Azide free (AB248849)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Reactivity data
Product details
ab248849 is the carrier-free version of ab138497.
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CYP7B1 plays a role in the conversion of cholesterol derivatives into bile acids. It is not typically considered part of a larger protein complex but interacts locally with other enzymes for bile acid synthesis. The enzyme's activity ensures the maintenance of cholesterol balance by converting excess cholesterol into bile acids which are critical for fat digestion and absorption in the intestine. The products of CYP7B1 activity are further metabolized by other enzymes in the bile acid biosynthesis pathways contributing to lipid regulation in the body.
Pathways
CYP7B1 is integral to the alternative bile acid synthesis pathway distinguishing it from the classic pathway. This pathway provides a mechanism to balance cholesterol levels when the primary pathway is insufficient. CYP7B1 also relates functionally to CYP7A1 another enzyme involved in bile acid synthesis although CYP7A1 belongs to the classic pathway. These enzymes ensure that cholesterol conversion is adaptable and responsive to physiological needs maintaining lipid and energy homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Journal of personalized medicine 12: PubMed35207643
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com